Enlivex Therapeutics Ltd Capital Reinvestment Ratio

Latest as of March 2020: 0.05x

Enlivex Therapeutics Ltd capital reinvestment ratio. Enlivex Therapeutics Ltd (ENLV) has a Capital Reinvestment Ratio of 0.05x as of March 2020, meaning it reinvests 0% of its operating cash flow (ILA779.00K) in capital expenditures (ILA39.00K). Check ENLV capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.05x

Capex / Operating Cash Flow

Operating Cash Flow

ILA779.00K

ILA

Capital Expenditures

ILA39.00K

ILA

Data as of

Mar 2020

Most recent filing

Enlivex Therapeutics Ltd Capital Reinvestment Ratio by Year (None–None)

Enlivex Therapeutics Ltd capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see ENLV operating cash flow.

Year	Reinvestment Ratio	Operating CF (ILA)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow